200 related articles for article (PubMed ID: 19125003)
1. New therapeutic agents in ovarian cancer.
Collinson F; Jayson G
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):44-53. PubMed ID: 19125003
[TBL] [Abstract][Full Text] [Related]
2. Targeted agents in ovarian cancer.
Kristedja TS; Morgan RJ; Cristea M
Womens Health (Lond); 2010 Sep; 6(5):679-94. PubMed ID: 20887168
[TBL] [Abstract][Full Text] [Related]
3. Bevacizumab combination therapy: a review of its use in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Dhillon S
BioDrugs; 2013 Aug; 27(4):375-92. PubMed ID: 23728884
[TBL] [Abstract][Full Text] [Related]
4. New drugs for ovarian cancer.
Kaye SB
Clin Adv Hematol Oncol; 2008 Feb; 6(2):91-3. PubMed ID: 18347558
[No Abstract] [Full Text] [Related]
5. Angiogenesis inhibitors for the treatment of ovarian cancer.
Gaitskell K; Martinek I; Bryant A; Kehoe S; Nicum S; Morrison J
Cochrane Database Syst Rev; 2011 Sep; (9):CD007930. PubMed ID: 21901715
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab in the treatment of ovarian cancer.
Han ES; Monk BJ
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1339-45. PubMed ID: 17944559
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis as a strategic target for ovarian cancer therapy.
Spannuth WA; Sood AK; Coleman RL
Nat Clin Pract Oncol; 2008 Apr; 5(4):194-204. PubMed ID: 18268546
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis as a target for the treatment of ovarian cancer.
Shaw D; Clamp A; Jayson GC
Curr Opin Oncol; 2013 Sep; 25(5):558-65. PubMed ID: 23942301
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic drugs in ovarian cancer.
Kumaran GC; Jayson GC; Clamp AR
Br J Cancer; 2009 Jan; 100(1):1-7. PubMed ID: 19002176
[TBL] [Abstract][Full Text] [Related]
10. Current status on biologic therapies in the treatment of epithelial ovarian cancer.
Han ES; Lin P; Wakabayashi M
Curr Treat Options Oncol; 2009 Apr; 10(1-2):54-66. PubMed ID: 19381822
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis inhibition in the treatment of lung cancer.
Vokes E; Herbst R; Sandler A
Clin Adv Hematol Oncol; 2006 Nov; 4(11 Suppl 23):1-10; quiz 11-2. PubMed ID: 17143257
[TBL] [Abstract][Full Text] [Related]
12. An update on current and emerging therapies for epithelial ovarian cancer: Focus on poly(adenosine diphosphate-ribose) polymerase inhibition and antiangiogenesis.
Chung C; Lee R
J Oncol Pharm Pract; 2017 Sep; 23(6):454-469. PubMed ID: 27357817
[TBL] [Abstract][Full Text] [Related]
13. First-line chemotherapy in epithelial ovarian cancer.
Bookman MA
Clin Obstet Gynecol; 2012 Mar; 55(1):96-113. PubMed ID: 22343232
[TBL] [Abstract][Full Text] [Related]
14. Drug insight: VEGF as a therapeutic target for breast cancer.
Schneider BP; Sledge GW
Nat Clin Pract Oncol; 2007 Mar; 4(3):181-9. PubMed ID: 17327858
[TBL] [Abstract][Full Text] [Related]
15. New ways to successfully target tumor vasculature in ovarian cancer.
Yang X; Shen F; Hu W; Coleman RL; Sood AK
Curr Opin Obstet Gynecol; 2015 Feb; 27(1):58-65. PubMed ID: 25502429
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of trebananib (AMG 386) in treating epithelial ovarian cancer.
Al Wadi K; Ghatage P
Expert Opin Pharmacother; 2016; 17(6):853-60. PubMed ID: 26933765
[TBL] [Abstract][Full Text] [Related]
17. Molecular/genetic therapies in ovarian cancer: future opportunities and challenges.
Ziebarth AJ; Landen CN; Alvarez RD
Clin Obstet Gynecol; 2012 Mar; 55(1):156-72. PubMed ID: 22343235
[TBL] [Abstract][Full Text] [Related]
18. [New biological treatments for lung cancer].
Zalcman G; Richard N; Bergot E
Rev Pneumol Clin; 2007 Feb; 63(1):20-8. PubMed ID: 17457280
[TBL] [Abstract][Full Text] [Related]
19. Novel antiangiogenic therapies in ovarian cancer.
Stuckey A; Dizon DS
Womens Health (Lond); 2012 Jul; 8(4):447-53. PubMed ID: 22757735
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study.
Asmane I; Kurtz JE; Bajard A; Guastalla JP; Meeus P; Tredan O; Labidi Galy I; Moullet I; Ardisson P; Vincent L; Coeffic D; Dufresne A; Bergerat JP; Ray-Coquard I
Bull Cancer; 2011 Oct; 98(9):80-9. PubMed ID: 21926034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]